SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dave who wrote (229)2/26/2001 9:30:42 PM
From: Jim Oravetz   of 370
 
Vion today announced that U.S. Patent No. 6,190,657 was issued from the U.S. Patent and Trademark Office. This patent, entitled "Vectors For The Diagnosis and Treatment of Solid Tumors Including Melanoma," adds an important component to Vion's intellectual property estate, as it provides coverage for the use of tumor-selective Salmonella bacteria for treating cancer.

The patent was awarded to Yale faculty members John M. Pawelek, Ph.D., Kenneth B. Low, Ph.D. and
David G. Bermudes, Ph.D. Dr. Bermudes is currently the Director of Biology at Vion. The technology
covered by the patent has been exclusively licensed on a worldwide basis to Vion.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News